B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC26A4

MOLECULAR TARGET

solute carrier family 26 member 4

UniProt: O43511NCBI Gene: 51721 compounds

SLC26A4 (solute carrier family 26 member 4) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC26A4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Salicylic Acid0.691

About SLC26A4 as a Drug Target

SLC26A4 (solute carrier family 26 member 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented SLC26A4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC26A4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.